4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-25-028030
Director sold 850 shares at $1.46 ($1,237)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Camaisa Allan Director | 2025-12-12 | Sale | −850 | $1.46 | $1,237 | 76,952 | I |
| Open-market sales · 850 sh · avg $1.46 · $1,237 | |||||||
Loading xslF345X05/ownership.xml…